How Daniel Druckers work on GLP-1s reaches beyond Ozempic #uoft @uoft
How Daniel Druckers work on GLP-1s reaches beyond Ozempic #uoft  @uoft
Uploaded November 2025 | Updated November 2026, 2 days ago
You may know Ozempic or Wegovy, but did you know Daniel Drucker’s groundbreaking work on glucagon-like peptide-1 (GLP-1) is what makes them possible?

Daniel Drucker, physician, senior investigator at the Lunenfeld-Tanenbaum Research Institute at @SinaiHealth University Professor at @UofTMed is one of the five researchers who uncovered the science behind GLP-1. The groundbreaking research has transformed millions of lives with new treatments for diabetes and weight loss, and shows huge promise in treating a wide array of other conditions, from kidney disease to neurological disorders.

Learn more about Drucker’s award-winning work at uoft.me/dan-drucker
How Daniel Druckers work on GLP-1s reaches beyond Ozempic #uoft#UofTGrad26 I How I Got Here...My U of T | Formula Racing Team Q&A Rapid Fire #uoft #myuoftJane Corkin, U of T honorary degree recipient, November 1, 2024Meet the physicist who discovered how to trap lightThe Science of Soccer #uoftMy U of T | Formula Racing Team #uoft #myuoftGeoffrey Hintons advice to students: Find out what problem really excites youThe #UofT scientist decoding the cosmos 🌌What’s actually inside a #uoft student’s bag?Jennifer Bernard, U of T honorary degree recipient, June 10, 2026SGS; Faculty of Law; Munk School of Global Affairs & Public Policy Spring 2026 Convocation
University of Toronto |

How Daniel Drucker's work on GLP-1s reaches beyond Ozempic #uoft

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER